Nebula Genomics

Nebula Genomics

Created using Figma
Created using Figma
Farmaceutische en biotechbedrijven geven elk jaar miljarden dollars uit om genomische gegevens te verwerven. Wetenschappers hebben grote genomische datasets nodig om de oorzaken van ziekten te identificeren en genezingen te ontwikkelen. De groei van de markt voor genomische gegevens wordt echter belemmerd door kleine gegevenshoeveelheden, fragmentatie van gegevens, gebrek aan gegevensstandaardisatie en trage gegevensverzameling. Nebula Genomics maakt gebruik van blockchain-technologie om de tussenpersoon te elimineren en mensen in staat te stellen hun persoonlijke genomische gegevens te bezitten. Dit zal effectief de sequencingkosten verlagen en de gegevensprivacy verbeteren, wat resulteert in groei van genomische gegevens. Ons open protocol zal de genomische datagroei benutten door data-inkopers in staat te stellen op efficiënte wijze gestandaardiseerde data te verzamelen van vele individuen en genomische databanken.
Risico: zeer hoog
jun., 2018
jun., 2018
100% voltooid
Opgehaald geld - geen gegevens
past
Details token
Geaccepteerde valuta's
ETH
Bedrijfsgegevens
Geregistreerd land
United States
aanvullende details
KYC
Ja
Categorieën
Gezondheid, Big Data

Over Nebula Genomics

The first human genome was sequenced in 2001 at a cost of $3 billion. Today, human genome sequencing costs less than $1000, and in a few years the price will drop below $100. Thus, personal genome sequencing will soon be widely adopted as it enables better diagnosis, disease prevention, and personalized therapies. Furthermore, if genomic data is shared with researchers, the causes of many diseases will be identified and new drugs developed. These opportunities are creating a genomic data market worth billions of dollars.

Nebula Genomics seeks to lead this emerging market by understanding and overcoming key obstacles. We will spur genomic data growth by significantly reducing the costs of personal genome sequencing, enhancing genomic data protection, enabling buyers to efficiently acquire genomic data, and addressing the challenges of genomic big data. We will accomplish this through decentralization, cryptography, and utilization of the blockchain.

SEQUENCING COSTS - The Nebula peer-to-peer network will enable data buyers to acquire genomic data directly from data owners without middlemen. This will enable data owners to receive sequencing subsidies from data buyers and profit from sharing their data. Reducing sequencing costs will accelerate growth of genomic data.

DATA PROTECTION - Data owners will privately store their genomic data and control access to it. Shared data will be protected through zero-trust, encryption-based secure computing. Data owners will remain anonymous, while data buyers will be required to be fully transparent about their identity. The Nebula blockchain will immutably store all data transaction records. Addressing data privacy concerns will likewise accelerate growth of genomic data.

DATA ACQUISITION - The Nebula network will aggregate genomic data from individuals and genomic databanks and thereby address the problem of genomic data fragmentation. Direct communication with data owners and a smart survey tool will enable data buyers to collect high quality trait information. Utilization of standardized data formats will facilitate data curation. Smart contracts will automate and thereby accelerate data purchases.

GENOMIC BIG DATA - Genomic big data is projected to outgrow video and text data within the next few years. Through decentralized data storage, flexible utilization of available computing power and efficient file transfers enabled by space-efficient data encoding, the Nebula network will absorb the forthcoming data explosion.

Activiteit

Volgers:
25 880
VERY HIGH
tweets:
649
VERY HIGH
30 dagen groei:

Nebula Genomics Team

geverifieerd 0%

Aandacht. Het risico bestaat dat niet-geverifieerde leden feitelijk geen lid zijn van het team

George Church
Co-founder
geverifieerde
Dennis Grishin
Co-founder
geverifieerde
Kamal Obbad
Co-founder
geverifieerde
Armon Rahim
Growth Lead
geverifieerde
Kevin Quinn
Engineer
geverifieerde

Advisors

geverifieerd 0%

Aandacht. Het risico bestaat dat niet-geverifieerde leden feitelijk geen lid zijn van het team

Mirza Cifric
Advisor
geverifieerde
Preston Estep
Advisor
geverifieerde
Yining Zhao
Advisor
geverifieerde
Drew Volpe
Advisor
geverifieerde
Joe Urgo
Advisor
geverifieerde
D. A. Wallach
Advisor
geverifieerde
1.88
negative
5.0 13
ICO Profiel Visie Activiteit potentieel Artikel Team

% name% Reviews

ICO Pantera
A

Advantages.
1. A very competent gene sequencing company called `veritas` is the parent company.
2. It provides genetic sequencing services rather than simple genetic testing services. It is recognized that it is promising market, and it can be said that there are almost no rivals on ICO market.
3. Team is strong and institutional investors who are solid. Advisors, especially George Church, are prominent.
A complementary point
1. There are strong market competitors including 23andme.
2. There are not many developers yet, and they are showing weakness in marketing. Active marketing is especially important in the coin market.
3. No code has been published yet, and no tokensale has been published.

Lees verder
Crypto Sherlock
6.8
Lees verder
  • Omdat er mogelijk tijdsverschillen zijn in informatie-updates, moet nauwkeurige informatie over elk ICO-project worden geverifieerd via de officiële website of andere communicatiekanalen.
  • Deze informatie is geen suggestie of advies over beleggen in ICO-financiering. Onderzoek de relevante informatie zelf grondig en besluit over ICO-deelname.
  • Als u denkt dat er problemen of problemen zijn die moeten worden gecorrigeerd voor deze inhoud, of als u uw eigen ICO-project wilt indienen dat wordt vermeld, e-mail ons.
Lees de disclaimer en risicowaarschuwing. Laat disclaimer en risicowaarschuwing zien.
Planning an ICO? We can help with a wide range of support for all stages of your ICO